跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 111,618 条关于
“Safety Review Committee”
全部
111,618
临床试验
89,641
药物
42
机构
62
资讯
21,873
去年
Genprex's Reqorsa Gene Therapy Advances to Highest Dose in Phase 1 SCLC Trial
去年
EMA Safety Committee Initiates Review of Levamisole Following Fatal Leukoencephalopathy Case
去年
PYC Therapeutics Advances PYC-003 to Second Cohort in Phase Ia Trial for Polycystic Kidney Disease
去年
Island Pharmaceuticals Completes Patient Dosing in Phase 2b PROTECT Trial for Dengue Fever Treatment
2年前
Clarity Pharmaceuticals' 67Cu-SAR-bisPSMA Shows Promise in mCRPC Trial
去年
Artelo Biosciences' ART26.12 Advances in Phase 1 Trial for Neuropathic Pain
去年
Aptose's Tuspetinib-Based Triple Therapy Shows Promise in Newly Diagnosed AML Patients
去年
TransCode Therapeutics Completes Cohort 3 Dosing in Phase 1 Trial of TTX-MC138 for Metastatic Cancers
11个月前
Eleva's CPV-104 Advances to Phase 1b Testing in C3G Patients After Successful Safety Evaluation
去年
Yoltech Therapeutics' YOLT-201 Shows Promise in Phase I ATTR Amyloidosis Trial
第 1 页,共 2188 页
上一页
下一页